Steven D. Nathan, M., Juergen Behr, M., Vincent Cottin, M., Lisa Lancaster, M., Peter Smith, P., CQ Deng, P., . . . Kevin R. Flaherty, M. Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary FibrosisTake-Home Points. Elsevier.
Chicago Style (17th ed.) CitationSteven D. Nathan, MD, et al. Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary FibrosisTake-Home Points. Elsevier.
MLA (9th ed.) CitationSteven D. Nathan, MD, et al. Study Design and Rationale for the TETON-PPF Phase 3, Randomized, Controlled Clinical Trial of Inhaled Treprostinil in the Treatment of Progressive Pulmonary FibrosisTake-Home Points. Elsevier.